Co-Authors
This is a "connection" page, showing publications co-authored by MICHAEL BELFORT and ALEX VIDAEFF.
Connection Strength
3.080
-
Antenatal corticosteroids in COVID-19 perspective. World J Exp Med. 2021 Sep 20; 11(4):37-43.
Score: 0.810
-
Evidence based medicine - decades later. J Matern Fetal Neonatal Med. 2022 Feb; 35(3):472-475.
Score: 0.724
-
Interpreting a randomized trial report: evidence-based practice for the clinician. J Matern Fetal Neonatal Med. 2016; 29(16):2640-4.
Score: 0.538
-
Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth. Patient Prefer Adherence. 2013; 7:683-91.
Score: 0.459
-
Updating the balance between benefits and harms of antenatal corticosteroids requires appropriate causal inference: a reply. Am J Obstet Gynecol. 2023 07; 229(1):81.
Score: 0.223
-
Updating the balance between benefits and harms of antenatal corticosteroids. Am J Obstet Gynecol. 2023 02; 228(2):129-132.
Score: 0.219
-
Retrospective surveys of obstetric red cell transfusion practice in the UK and USA. Int J Gynaecol Obstet. 2017 Dec; 139(3):342-345.
Score: 0.038
-
Adrenomedullin2 (ADM2)/Intermedin (IMD): A Potential Role in the Pathophysiology of Preeclampsia. J Clin Endocrinol Metab. 2016 11; 101(11):4478-4488.
Score: 0.036
-
Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia. Dis Markers. 2015; 2015:263109.
Score: 0.034